A
Aveanna Healthcare Holdings Inc
NASDAQ:AVAH
Aveanna Healthcare Holdings Inc
NASDAQ:AVAH
Price:
2.48 USD
2.48%
Market Closed
Updated:
May 10, 2024
Aveanna Healthcare Holdings Inc
Cost of Revenue
|
Aveanna Healthcare Holdings Inc
Cost of Revenue Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
A
|
Aveanna Healthcare Holdings Inc
NASDAQ:AVAH
|
Cost of Revenue
-$1.3B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Cost of Revenue
-$8.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
0%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cost of Revenue
-$6.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-4%
|
|
|
CVS Health Corp
NYSE:CVS
|
Cost of Revenue
-$307.3B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-11%
|
|
|
Cigna Corp
NYSE:CI
|
Cost of Revenue
-$180.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cost of Revenue
-$8.9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-9%
|
See Also
What is Aveanna Healthcare Holdings Inc's Cost of Revenue?
Cost of Revenue
-1.3B
USD
-1.3B
USD
Based on the financial report for Dec 30, 2023, Aveanna Healthcare Holdings Inc's Cost of Revenue amounts to -1.3B USD.
What is Aveanna Healthcare Holdings Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-9%
-9%
Over the last year, the Cost of Revenue growth was -5%. The average annual Cost of Revenue growth rates for Aveanna Healthcare Holdings Inc have been -8% over the past three years , -9% over the past five years .
You don't have any saved screeners yet
